ACRS

Quote

Short

News

Articles

Message Board

Aclaris Therapeutics Inc. (NASDAQ : ACRS ) News

Aclaris Therapeutics Inc. (NASDAQ: ACRS) News Releases

ACRS News Releases

May 28, 2026 08:30:00 am

GlobeNewswire

Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

May 14, 2026 02:30:46 pm

SeekingAlpha

Aclaris Therapeutics, Inc. (ACRS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

May 08, 2026 08:30:00 am

GlobeNewswire

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

May 07, 2026 07:01:32 am

SeekingAlpha

Aclaris Therapeutics GAAP EPS of -$0.15 beats by $0.01, revenue of $2M beats by $0.68M

May 07, 2026 06:59:00 am

GlobeNewswire

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

May 05, 2026 08:15:09 am

KlickAnalytics

ACRS Price Target Alert: $11.00. Issued by Piper Sandler

April 28, 2026 02:01:56 pm

SeekingAlpha

Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates Transcript

April 28, 2026 06:30:00 am

GlobeNewswire

Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4R? Bispecific Antibody, and Announces Lichen Planus as Lead Indication f

April 27, 2026 04:45:00 pm

GlobeNewswire

Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026

April 08, 2026 08:30:00 am

GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account